“For example, prior studies have suggested that variants in CYP1A2, (a gene) encoding the enzyme responsible for more than 95 percent of caffeine metabolism, may alter associations of coffee drinking with cardiovascular-related outcomes, with slower caffeine metabolizers having higher risk of developing hypertension (high blood pressure) or having a myocardial infarction (heart attack) relative to their non-drinking counterparts, whereas faster caffeine metabolizers who drink coffee are at no or lower risk of these outcomes.”
Other studies have tried to pinpoint exactly what in caffeine is helping to halt the onset of these diseases. A 2014 study (14) found that caffeine blocks various tau receptors (a protein that contributes to brain cell degeneration). Another study found that caffeinated coffee increased GCSF (15) - a substance greatly decreased in Alzheimer’s patients - levels in the bloodstream.